These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 11594903)
1. Affordable prescriptions for the elderly. Bodenheimer TS JAMA; 2001 Oct; 286(14):1762-3. PubMed ID: 11594903 [No Abstract] [Full Text] [Related]
2. Medicare: the basics. Goldberg E Pa Nurse; 2006 Jun; 61(2):11. PubMed ID: 16871978 [No Abstract] [Full Text] [Related]
3. Medicare overpaid dollar 110 million for part B drugs. Med Health; 2006 Mar; 60(13):2-3. PubMed ID: 16562555 [No Abstract] [Full Text] [Related]
4. Medicare Part D: decision, decisions, decisions. Medicare prescription drug coverage should save many people some money, but it puts a new burden on beneficiaries to be smart shoppers. Harv Health Lett; 2005 Dec; 31(2):4-5. PubMed ID: 16440454 [No Abstract] [Full Text] [Related]
5. Prescription drug prices in Canada. Gross D Issue Brief (Public Policy Inst (Am Assoc Retired Pers)); 2003 Jun; (IB62):1-22. PubMed ID: 12807123 [No Abstract] [Full Text] [Related]
6. DTCA not real advertising issue. Saunders B N Z Med J; 2003 Sep; 116(1182):U611. PubMed ID: 14581960 [No Abstract] [Full Text] [Related]
7. Supplemental insurance and use of effective cardiovascular drugs among elderly medicare beneficiaries with coronary heart disease. Federman AD; Adams AS; Ross-Degnan D; Soumerai SB; Ayanian JZ JAMA; 2001 Oct; 286(14):1732-9. PubMed ID: 11594898 [TBL] [Abstract][Full Text] [Related]
8. Access to Medicare Part D gap coverage more scarce in 2007. Consult Pharm; 2007 Jan; 22(1):60-1. PubMed ID: 17380599 [No Abstract] [Full Text] [Related]
9. Medicare prescription drugs: a benefit whose time has come. Benjamin GC Physician Exec; 1999; 25(4):89-90. PubMed ID: 10557496 [TBL] [Abstract][Full Text] [Related]
10. Supplemental Insurance for Community Aged and Disabled Beneficiaries: 1999. Murray LA; Eppig FJ Health Care Financ Rev; 2002; 23(3):161-3. PubMed ID: 12500354 [No Abstract] [Full Text] [Related]
11. Was Part D a giveaway to the pharmaceutical industry? Newhouse JP; Seiguer E; Frank RG Inquiry; 2007; 44(1):15-25. PubMed ID: 17583259 [TBL] [Abstract][Full Text] [Related]
12. Estimating the moral-hazard effect of supplemental medical insurance in the demand for prescription drugs by the elderly. Coulson NE; Terza JV; Neslusan CA; Stuart BC Am Econ Rev; 1995 May; 85(2):122-6. PubMed ID: 10160523 [No Abstract] [Full Text] [Related]
13. A multidimensional framework for specialty drug management. Bell GK; Baumann SA Manag Care; 2013 Mar; 22(3):30-5. PubMed ID: 23610804 [No Abstract] [Full Text] [Related]
14. Average out-of-pocket health care costs for Medicare+Choice enrollees increase substantially in 2002. Gold M; Achman L Issue Brief (Commonw Fund); 2002 Nov; (575):1-8. PubMed ID: 12425302 [No Abstract] [Full Text] [Related]
15. Exploring the influence of insurance effects on prescription drug coverage. McKercher PL; Taylor SD Ann Pharmacother; 2002 Nov; 36(11):1805-6. PubMed ID: 12432894 [No Abstract] [Full Text] [Related]